The global In-vitro Toxicology Assays market size is expected to be worth around US$ 4.9 billion by 2030, according to a new report by Vision Research Reports.
The global In-vitro Toxicology Assays market size was valued at US$ 1,436.1 million in 2020 and is anticipated to grow at a CAGR of 12.2% during forecast period 2021 to 2030.
Report Coverage
Report Scope | Details |
Market Size | USD 4.9 billion by 2030 |
Growth Rate | CAGR of 12.2% From 2021 to 2030 |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Test type, Technology,Application, Method |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | Stemina Biomarker Discovery, Inc.; Broughton Nicotine Services; Labstat International, Inc.; IONTOX; TOXIKON; Integrated Laboratory Systems; Enthalpy Analytical; PBR Laboratories, Inc. |
Growth Factors
Growing adoption of high throughput techniques in cannabis testing, legalization of medical cannabis, and growing awareness regarding the potential hazards of nicotine consumption have majorly driven the market throughout the forecast period.
The legalization of medical cannabis is underway globally, including in countries such as Germany, Australia, and Israel. The market is gaining momentum in the Asia Pacific region, with Thailand having fully legalized medicinal cannabis. Thus, increasing legalization of medical cannabis is expected to drive the market growth to a major extend. In addition, technological advancements in cellular assays have boosted the market growth.
By Test Type Analysis
The nicotine testing segment dominated the market and accounted for the largest revenue share of 55.0% in 2020. This can be attributed to the presence of an effective regulatory structure for the safe consumption of nicotine-containing products. Rising consumption of tobacco and the growing focus of research studies on nicotine testing utilization are factors expected to expedite segment growth.
The cannabis testing segment also captured a significant market share as it is used for detecting the quantity of cannabis substances in samples. This testing aids in monitoring regulated cannabis products in the market. Rising acceptance of cannabis for medical use is further anticipated to boost the market growth throughout the forecast period.
By Technology Analysis
The mass spectrometry segment dominated the market and accounted for the largest revenue share of 25.9% in 2020. Increasing inspection by regulatory bodies will boost segment growth, as it assists in identifying unknown substances and quantify known substances. The rising focus of research studies on evaluating applications of mass spectrometry is aiding segment growth.
The 3D cell culture technology segment is anticipated to grow at a rapid pace during the forecast period owing to the growing number of in-vitro toxicology laboratories in key regions and the increasing number of tests being conducted by them. Technological advancements in 3D cell culture technology to expand its application across various research studies are also driving the segment.
By Application Analysis
The cytotoxicity testing segment dominated the market and accounted for the largest revenue share of 27.2% in 2020. The segment is expected to continue its dominance over the forecast period. The rising significance of these testing methods in various technologies is considered to be a driving factor for market growth.
3D cell cytotoxicity evaluation system technology can be used to assess cigarette smoke; this system offers faster results without any intervention of skilled force.
By Method Analysis
The cellular assay testing method segment dominated the market and accounted for the largest revenue share of 58.8% in 2020 due to the rise in drug discovery screening to quantify cytotoxicity and other bio-chemicals. The launch of new products for cannabis-based medicine testing is further driving the market.
Advancements in cell-based assays are anticipated to positively impact revenue generation of the segment, owing to delivery of rapid and accurate results without any intervention of skill-force.
By Regional Analysis
North America dominated the in-vitro toxicology assays market for cannabis and nicotine testing and accounted for the largest revenue share of 44.4% in 2020. This growth in the region can be attributed to the presence of a substantial number of market players and legalized usage of cannabis and nicotine for medicinal and recreational purposes.
Asia Pacific, the market is likely to witness the fastest growth over the forecast period. The legalization of cannabis and nicotine-related products is expected to be the key market driver over the forecast period. It is anticipated that India will be the fastest-growing market for in-vitro toxicology assays in the region.
Key Players
Stemina Biomarker Discovery, Inc.
Broughton Nicotine Services
Labstat International, Inc.
IONTOX
TOXIKON
Integrated Laboratory Systems
Enthalpy Analytical
PBR Laboratories, Inc.
Market Segmentation
Test Type
Cannabis Testing
Nicotine Testing
Technology
3D Cell Culture Technology
Mass Spectrometry
Flow Cytometry
Others
Application
Genetic Toxicity Testing
Carcinogenicity Testing
Cytotoxicity Testing
Mutagenicity Testing
Others
Method
Cellular Assay
Live Cells
High Throughput / High Content Screening
Molecular Imaging
Others
Fixed Cells
Others
Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Asia Pacific
Japan
China
India
Australia
Singapore
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
The In-vitro Toxicology Assays market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of In-vitro Toxicology Assays market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global In-vitro Toxicology Assays market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In-vitro Toxicology Assays market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted In-vitro Toxicology Assays market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the In-vitro Toxicology Assays capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of In-vitro Toxicology Assays by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global In-vitro Toxicology Assays market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major In-vitro Toxicology Assays market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of In-vitro Toxicology Assays market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the In-vitro Toxicology Assays industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
In-vitro Toxicology Assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to In-vitro Toxicology Assays market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of In-vitro Toxicology Assays market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new In-vitro Toxicology Assays market. These factors have benefited the growth of the global market for In-vitro Toxicology Assays. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for In-vitro Toxicology Assays. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of In-vitro Toxicology Assays are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global In-vitro Toxicology Assays Market, By Test Type
7.1. In-vitro Toxicology Assays Market, by Test Type, 2021-2030
7.1.1. Cannabis Testing
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Nicotine Testing
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global In-vitro Toxicology Assays Market, By Technology
8.1. In-vitro Toxicology Assays Market, by Technology, 2021-2030
8.1.1. 3D Cell Culture Technology
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Mass Spectrometry
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Flow Cytometry
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global In-vitro Toxicology Assays Market, By Application
9.1. In-vitro Toxicology Assays Market, by Application, 2021-2030
9.1.1. Genetic Toxicity Testing
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Carcinogenicity Testing
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Cytotoxicity Testing
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Mutagenicity Testing
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global In-vitro Toxicology Assays Market, By Method
10.1. In-vitro Toxicology Assays Market, by Method, 2021-2030
10.1.1. Cellular Assay
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Others
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Technology (2017-2030)
11.1.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.4. Market Revenue and Forecast, by Method (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.4. Market Revenue and Forecast, by Method (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.4. Market Revenue and Forecast, by Method (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.4. Market Revenue and Forecast, by Method (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.4. Market Revenue and Forecast, by Method (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.4. Market Revenue and Forecast, by Method (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.4. Market Revenue and Forecast, by Method (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.4. Market Revenue and Forecast, by Method (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.4. Market Revenue and Forecast, by Method (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.4. Market Revenue and Forecast, by Method (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.4. Market Revenue and Forecast, by Method (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.4. Market Revenue and Forecast, by Method (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.4. Market Revenue and Forecast, by Method (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.4. Market Revenue and Forecast, by Method (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.4. Market Revenue and Forecast, by Method (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.4. Market Revenue and Forecast, by Method (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.4. Market Revenue and Forecast, by Method (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.4. Market Revenue and Forecast, by Method (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.4. Market Revenue and Forecast, by Method (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.4. Market Revenue and Forecast, by Method (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Test Type (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.4. Market Revenue and Forecast, by Method (2017-2030)
Chapter 12. Company Profiles
12.1. Stemina Biomarker Discovery, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Broughton Nicotine Services
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Labstat International, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. IONTOX
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. TOXIKON
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Integrated Laboratory Systems
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Enthalpy Analytical
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. PBR Laboratories, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms